Duopharma Biotech (7148.KL) Earnings Analysis
Duopharma Biotech (7148.KL) next reports earnings on 2026-08-13. Last quarter (2026-05-14) it beat with EPS 0.032 MYR vs 0.032 MYR est (0%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 13.20.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 7148.KL next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
7148.KL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | 0.032 MYR | 0.032 MYR | 0% | Beat |
| 2026-02-26 | 0.02 MYR | 0.076 MYR | -73.7% | Miss |
| 2025-08-21 | 0.021 MYR | n/a | n/a | n/a |
| 2025-05-15 | 0.02665 MYR | n/a | n/a | n/a |
| 2025-02-20 | 0.01568 MYR | n/a | n/a | n/a |
| 2024-11-08 | 0.01621 MYR | n/a | n/a | n/a |
| 2024-08-15 | 0.01735 MYR | n/a | n/a | n/a |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
7148.KL valuation and analyst view
| Trailing P/E | 13.20 |
|---|---|
| Trailing EPS | 0.0962 MYR |
| Price / book | 1.61 |
| Dividend yield | 3.58% |
| Market cap | 1.19B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Duopharma Biotech (7148.KL)'s next earnings date?
Duopharma Biotech is next scheduled to report on 2026-08-13.
Did 7148.KL beat earnings last quarter?
In its 2026-05-14 report, 7148.KL posted EPS of 0.032 MYR versus a 0.032 MYR estimate — a beat of 0%.
What is 7148.KL's earnings track record?
Over the last 2 reported quarters with consensus data, 7148.KL beat estimates 1 times (50%).
What is 7148.KL's current P/E ratio and EPS?
7148.KL trades at a trailing P/E of 13.20 on trailing EPS of 0.09619706801449568 MYR.
What do analysts rate 7148.KL?
7148.KL has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.